These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36192346)

  • 1. The challenges of clinical trials in rare diseases.
    Mellerio JE
    Br J Dermatol; 2022 Oct; 187(4):453-454. PubMed ID: 36192346
    [No Abstract]   [Full Text] [Related]  

  • 2. Challenges associated with clinical trials for inherited and orphan retinal diseases.
    Fishman GA
    Retina; 2005 Dec; 25(8 Suppl):S10-S12. PubMed ID: 16374308
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical trial strategies for rare neurodevelopmental disorders: challenges and opportunities.
    Krishnan ML; Berry-Kravis E; Capal JK; Carpenter R; Gringras P; Hipp JF; Miller MT; Mingorance A; Philpot BD; Pletcher MT; Rotenberg A; Tjeertes J; Wang PP; Willgoss T; de Wit MC; Jeste SS
    Nat Rev Drug Discov; 2021 Sep; 20(9):653-654. PubMed ID: 34002058
    [No Abstract]   [Full Text] [Related]  

  • 4. A network of patients with orphan retinal diseases for clinical trials: goals, structure, challenges.
    Weleber RG
    Retina; 2005 Dec; 25(8 Suppl):S66-S67. PubMed ID: 16374344
    [No Abstract]   [Full Text] [Related]  

  • 5. The promise and challenges of rare cancer research.
    Komatsubara KM; Carvajal RD
    Lancet Oncol; 2016 Feb; 17(2):136-138. PubMed ID: 26868336
    [No Abstract]   [Full Text] [Related]  

  • 6. Rare Gynecologic Tumors: Coming of Age.
    Gershenson DM; Okamoto A; Ray-Coquard I
    Gynecol Oncol; 2020 Apr; 157(1):1-2. PubMed ID: 32241340
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical trials In BMT: ensuring that rare diseases and rarer therapies are well done.
    Shurin S; Krischer J; Groft SC
    Biol Blood Marrow Transplant; 2012 Jan; 18(1 Suppl):S8-11. PubMed ID: 22226117
    [No Abstract]   [Full Text] [Related]  

  • 8. [Purposefulness of using fuzzy logic approaches in the rare disease clinical trials].
    Kiseleva TS; Pagava KI; Korinteli IA; Korinteli MG; Shonvadze DN
    Georgian Med News; 2011 Apr; (193):22-4. PubMed ID: 21617269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should clinical trials be approached differently for rare cancers?
    Olver I
    Future Oncol; 2016 May; 12(10):1207-9. PubMed ID: 26939845
    [No Abstract]   [Full Text] [Related]  

  • 10. International rare cancers initiative.
    Keat N; Law K; Seymour M; Welch J; Trimble T; Lascombe D; Negrouk A
    Lancet Oncol; 2013 Feb; 14(2):109-10. PubMed ID: 23369681
    [No Abstract]   [Full Text] [Related]  

  • 11. A unifying strategy for clinical trials in rare urological malignancy.
    Nicholson S
    Nat Clin Pract Urol; 2008 Dec; 5(12):652-3. PubMed ID: 19015645
    [No Abstract]   [Full Text] [Related]  

  • 12. Methodology of clinical trials for rare diseases.
    Tudur Smith C; Williamson PR; Beresford MW
    Best Pract Res Clin Rheumatol; 2014 Apr; 28(2):247-62. PubMed ID: 24974061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical research in rare diseases: new challenges, opportunities and ethical issues].
    Alfonso Farnós I; Alcalde Bezhold G
    An Pediatr (Engl Ed); 2020 Oct; 93(4):219-221. PubMed ID: 32921623
    [No Abstract]   [Full Text] [Related]  

  • 14. [Methodology and management of clinical trials with small number of patients for rare diseases].
    Micallef J
    Presse Med; 2012 May; 41 Suppl 1():S32-4. PubMed ID: 22483773
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical trials in rare disease: challenges and opportunities.
    Augustine EF; Adams HR; Mink JW
    J Child Neurol; 2013 Sep; 28(9):1142-50. PubMed ID: 24014509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developing treatment strategies for rare cancers.
    Atkinson JM; Gilbertson RJ
    Oncotarget; 2011 Sep; 2(9):657. PubMed ID: 21969078
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical trials for rare lung diseases: lessons from lymphangioleiomyomatosis.
    Kinder B; McCormack FX
    Lymphat Res Biol; 2010 Mar; 8(1):71-9. PubMed ID: 20235889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trials and tribulations: improving outcomes for adolescents and young adults with rare and low survival cancers.
    Walczak A; Patterson P; Thomas D
    Med J Aust; 2018 Oct; 209(8):330-332. PubMed ID: 30309304
    [No Abstract]   [Full Text] [Related]  

  • 19. Patient-reported outcomes in clinical trials of rare diseases.
    Basch E; Bennett AV
    J Gen Intern Med; 2014 Aug; 29 Suppl 3(Suppl 3):S801-3. PubMed ID: 25029974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene therapy for rare diseases: summary of a National Institutes of Health workshop, September 13, 2012.
    O'Reilly M; Kohn DB; Bartlett J; Benson J; Brooks PJ; Byrne BJ; Camozzi C; Cornetta K; Crystal RG; Fong Y; Gargiulo L; Gopal-Srivastava R; High KA; Jacobson SG; Jambou RC; Montgomery M; Rosenthal E; Samulski RJ; Skarlatos SI; Sorrentino B; Wilson JM; Xie Y; Corrigan-Curay J
    Hum Gene Ther; 2013 Apr; 24(4):355-62. PubMed ID: 23517518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.